Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Terapia con protoni | da $22,000 | da $70,000 | da $80,000 |
| Chemioterapia per carcinoma mammario | da $19,200 | da $1,200 | da $15,000 |
| Brachiterapia | da $11,800 | da $3,465 | da $15,000 |
| Terapia protonica per il cancro alla prostata | - | da $30,000 | da $80,000 |
| Terapia protonica per il cancro al seno | - | da $30,000 | da $55,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro della cistifellea. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro della cistifellea e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro della cistifellea.
Il medico è un esperto di cancro al seno leader in Corea del Sud ed è riconosciuto tra i 100 migliori chirurghi al mondo per il cancro gastrico e al seno. Il medico ha introdotto la chirurgia conservativa del seno in Corea del Sud nel 1986 e ha inventato un intervento chirurgico unico per il cancro allo stomaco che minimizza il rischio di malattia da reflusso gastroesofageo. Attualmente, il medico dirige il Centro per il Cancro delle Donne presso il Centro Medico dell'Università Ewha Womans e ha precedentemente ricoperto il ruolo di Presidente dell'Ospedale Universitario Konkuk e Direttore dell'Ospedale del Centro per il Cancro della Corea. Il medico è anche un ricercatore attivo nella diagnosi e gestione del cancro al seno.<\/p>
Il dottore è un esperto in chirurgia oncoplastica e cancro al seno, con una vasta esperienza in istituzioni prestigiose. Il dottore possiede una laurea in medicina (M.D.) dal College of Medicine della Seoul National University e un master in chirurgia (M.S.) dalla stessa istituzione. Inoltre, il dottore ha conseguito una laurea in scienze biologiche (B.S.) presso il Korea Advanced Institute of Science and Technology (KAIST) e un dottorato di ricerca (Ph.D.) in chirurgia presso la Graduate School della Seoul National University.<\/p>
Il medico è una figura di spicco nel campo della chirurgia, ricoprendo ruoli di leadership come Direttore del Comitato di Formazione e Educazione presso la Società Chirurgica Coreana e Direttore del Comitato di Tecnologia dell'Informazione presso la Società Coreana di Coloproctologia. Il medico è anche Direttore del Consiglio degli Affari Chirurgici presso la Società Coreana di Gastroenterologia e Vicepresidente dell'Associazione Coreana dei Chirurghi Robotici.<\/p>
Con un solido background educativo dall'Università della Corea, il medico ha dimostrato competenza chirurgica a livello internazionale, inclusi la Facoltà di Medicina dell'Università Cinese di Hong Kong e l'Ospedale Tan Tock Seng a Singapore.<\/p>
South Korea is a top choice for gallbladder cancer due to its 32.1% five-year survival rate. High regional prevalence means surgeons perform massive volumes of complex hepatobiliary resections. Major centers like Samsung Medical Center and Asan Medical Center rank among the world's best for oncology.
Bookimed Expert Insight: Patient volume is the strongest indicator of quality here. Severance Hospital and Samsung Medical Center serve millions of patients annually. This massive scale allows surgeons to specialize in rare biliary variations that doctors in lower-volume regions rarely encounter. Choosing these high-traffic Seoul centers ensures your surgeon likely manages dozens of similar cases every month.
Patient Consensus: Patients note that the speed of the workup is impressive. They value moving from initial scans to the operating room much faster than in other medical systems.
South Korea houses elite oncology centers specialized in hepatobiliary cancers. Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital (SNUH) lead the nation in gallbladder care. These JCI-accredited facilities utilize advanced robotic surgery and proton therapy to manage complex malignancies with high precision.
Bookimed Expert Insight: While patients often seek brand names, our data shows a clear advantage in volume at Asan and Samsung. These centers manage over 45,000 surgeries annually. This massive throughput ensures their hepatobiliary teams handle more rare gallbladder cases than smaller regional clinics. Choosing these high-volume hubs leads to better surgical accuracy due to the repetitive experience of their specialized staff.
Patient Consensus: Patients note it is essential to look for hospitals with dedicated hepatobiliary teams. They emphasize that rapid staging and surgery coordination are more important than convenience since this cancer often requires fast action.
Korean oncology centers treat gallbladder cancer with aggressive protocols centered on surgical resection and systemic therapies. Specialists utilize JCI-accredited facilities to perform radical cholecystectomies and advanced robotic surgeries. Multidisciplinary teams integrate digital imaging and biomarker-targeted therapies to improve patient outcomes in complex cases.
Bookimed Expert Insight: Clinical data shows a high-volume trend at centers like Samsung Medical Center, which handles over 2,000,000 patients annually. This massive scale suggests that Korean surgeons often manage more gallbladder cases than Western counterparts. This experience is vital for achieving R0 resection margins during difficult liver-bed surgeries.
Patient Consensus: Patients note that Korean doctors move quickly to surgery if the tumor appears operable. They suggest confirming whether a plan includes liver and lymph node removal before starting.
South Korean clinics report a 5-year relative survival rate of 32.1% for gallbladder cancer patients. This success stems from high-volume centers performing complex surgeries soon after diagnosis. Specialized oncology facilities in Seoul utilize robotic systems and proton therapy to manage difficult cases.
Bookimed Expert Insight: Patient volume is a reliable indicator of surgical proficiency in Korea. Asan Medical Center treats over 2,500 inpatients daily and maintains a 90% success rate in organ transplants. This high procedural density suggests that surgeons here encounter complex gallbladder cases more frequently than those at smaller regional centers.
Patient Consensus: Many patients find that the success of their treatment depends almost entirely on whether the tumor was caught early enough for complete surgical removal. They often stress getting scans done quickly because gallbladder cancer is frequently discovered at an advanced stage.
Referral requirements for gallbladder cancer specialists in South Korea vary by hospital and insurance. International patients often self-refer by submitting medical records directly to tertiary centers. Local residents or those using specific health plans typically require a referral from a primary care physician to secure coverage.
Bookimed Expert Insight: Data shows that South Korea's top-tier hospitals are concentrated in Seoul and operate as high-capacity digital hubs. For example, Severance Hospital and Samsung Medical Center each manage over 2,000,000 patient visits annually. While individual clinic rules differ, submitting high-quality scans before arrival often bypasses redundant local testing. This allows specialists at digital-first hospitals like Seoul National University Bundang Hospital to plan surgery immediately upon your arrival.
Patient Consensus: Patients note that while self-referral is possible, a summary letter from a local doctor speeds up the scheduling process. Organizing all pathology reports and finding a translator or coordinator helps navigate the intake systems at large Korean cancer centers.